CLINICAL_TRIALS
trial_result
· 2011-10-26
Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines [Phase 3]
Summary
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo for the treatment of glabellar frown lines has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED